bioAffinity Technologies, Inc. (BIAF )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BIAF
- Company bioAffinity Technologies, Inc.
- Price $0.27
- Changes Percentage -4.61
- Change -0.0129
- Day Low $0.27
- Day High $0.32
- Year High $2.99
- Year Low $0.16
- Market Cap $9,383,051
- Price Avg 50 EMA (D) $0.41
- Price Avg 200 EMA (D) $1
- Exchange NASDAQ
- Volume 7,240,241
- Average Volume 12,475,591
- Open $0.32
- Previous Close $0.28
- EPS -0.71
- PE -0.47
- Earnings Announcement 2025-08-12 20:00:00
- Shares Outstanding $27,867,690
Company brief: BIOAFFINITY TECHNOLOGIES, INC. (BIAF )
- Healthcare
- Medical - Diagnostics & Research
- Ms. Maria Zannes J.D.
- https://www.bioaffinitytech.com
- US
- N/A
- 09-01-2022
- US09076W1099
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.